Today: 2 July 2026
Silver price today: SLV jumps nearly 7% as silver rebounds after record-high rout
30 December 2025
1 min read

Silver price today: SLV jumps nearly 7% as silver rebounds after record-high rout

NEW YORK, December 30, 2025, 13:30 ET — Regular session

Silver prices rebounded on Tuesday after a sharp pullback from record highs, pushing the iShares Silver Trust (SLV) up about 6.9% in New York trade. Spot silver was up 4.7% at $76.38 an ounce at 11:29 a.m. ET, a day after touching an all-time high of $83.62 and suffering its biggest one-day drop since August 2020. Analysts at Societe Generale pointed to CME Group’s move on Friday to raise the initial margin requirement for silver futures — the cash traders must post to hold positions — as a factor behind the volatility after silver’s 161% surge this year.

The whiplash matters because silver has become a pressure valve for year-end positioning, where profit-taking and risk limits can overwhelm day-to-day fundamentals. Thin liquidity into the final sessions of the year can magnify price gaps in both directions.

Markets were also bracing for Federal Reserve minutes due later in the session, with the dollar firming and Treasury yields edging higher. The dollar index was up 0.24% and the benchmark 10-year yield was around 4.13%, while spot gold rose 0.67% to $4,360.79 an ounce.

On Monday, spot silver slid 9.5% to $71.66 an ounce by 1:51 p.m. ET after hitting the $83.62 record earlier in the session, as investors booked profits after recent rallies. “The underlying fundamentals of supply constraints remain factors in the market,” said David Meger, director of metals trading at High Ridge Futures. Reuters

Margin changes matter because they hit leveraged traders first. When required collateral rises, investors either add cash fast or reduce exposure, which can turn a routine pullback into a forced liquidation.

Silver also trades on two narratives at once. It can behave like a haven when geopolitical risk rises, and like an industrial metal when investors focus on growth.

That mix helps explain why silver can outperform gold in rallies and then correct harder. Even after Tuesday’s bounce, the metal remained well below Monday’s peak.

Silver mining shares tracked the metal higher. First Majestic Silver (AG) rose about 3.3%, Pan American Silver (PAAS) gained 2.1% and Coeur Mining (CDE) climbed 1.3% in early afternoon trading.

SLV remains a key conduit for stock-market investors who want silver exposure without trading futures. Its jump on Tuesday underscored how quickly positioning can reset when prices swing.

Silver does not pay interest, so it tends to benefit when investors expect lower borrowing costs and softer real yields. A stronger dollar can offset that by pressuring commodities priced in greenbacks.

Traders will watch whether the Fed minutes reinforce expectations for policy easing in 2026 and how markets translate that into the dollar and yields. Any further changes to exchange margin requirements would also stay in focus after this week’s volatility.

For pricing, investors are watching whether silver can regain the $80 handle and hold above the mid-$70s without another sharp liquidation. Monday’s surge and reversal has made recent highs and lows reference points for short-term positioning.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Cramer Sees Moderna's Pipeline Opening Up Beyond Covid
    July 1, 2026, 7:50 PM EDT. CNBC's Jim Cramer said on Mad Money that Moderna now looks different than during the Covid rush, with a cancer pipeline and vaccines reaching outside infectious diseases. He sees many programs still years out but calls for buying pullbacks, pointing to Moderna's track to profits and new data from late-stage cancer trials-like the melanoma combo trial with Merck's Keytruda. Moderna shares have jumped almost 150% this year but still trade under pandemic highs. Cramer also mentions fresh regulatory wins, including FDA advisory backing for its flu shot and a European nod for its combined Covid-flu vaccine.
HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET
Previous Story

HFCL jumps 10% on heavy volumes even as MarketsMojo keeps “Strong Sell” callNEW YORK, December 29, 2025, 00:11 ET

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next
Next Story

Apple stock slips into 2026 as year-end tech pullback bites; AAPL earnings next

Go toTop